Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the NIH announed that researchers had designed ﾓminiproteinsﾔ that bound tightly to the SARS-CoV-2…
-
-
Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the FDA to amend the…
-
Serum Institute to produce additional 100 million Covid-19 vaccine doses for India and low-and middle-income countries
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
-
New look at COVID-19 cases does not support link between BCG vaccination and lower mortality
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…
-
Moderna announced publication in The NEJM of interim results from phase 1 study of its mRNA vaccine against COVID-19
On Sept. 29, 2020, Moderna announced the publication of the second interim analysis of the open-label Phase 1…
-
REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
-
AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19
On Sept. 29, 2020, AXIM Biotechnologies announced that it had filed a provisional patent for a first-in-class face…
-
Windtree announced FDA acceptance of IND application for phase 2 clinical trial studying KL4 Surfactant in acute lung injury in adults with COVID-19
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…
-
Biotechnology | NIH | Vaccine
COVID-19 vaccine generated immune response in older adults
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…
-
CDC | COVID-19 | Diagnostics | Non-Profit Research | WHO
Global partnership made available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries
On Sept. 28, 2020, the World Health Organization announced agreements to make available, for low and middle-income countries,…
-
ViroVax licensed adjuvant to be used in India’s first COVID-19 vaccine in human trials
On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…
-
DOD and HHS awarded $20 million contract to On Demand Pharmaceuticals to develop critical pharmaceutical ingredients
On Sept. 28, 2020, the U.S. Departments of Defense and Health and Human Services signed a $20 million…
-
NIH-funded study shed light on abnormal neural function in rare genetic disorder
On Sept. 28, 2020, a genetic study identified neuronal abnormalities in the electrical activity of cortical cells derived…
-
About 14% of cerebral palsy cases may be tied to brain wiring genes
On Sept. 28, 2020, in an article published in Nature Genetics, researchers confirmed that about 14% of all…
-
Regular COVID-19 testing for groups most likely to spread the virus more efficient, cost-effective than random testing
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
-
Hologic granted FDA Emergency Use Authorization for asymptomatic COVID-19 testing with Panther Fusion SARS-CoV-2 assay
On Sept. 28, 2020, Hologic announced that its Panther Fusionﾮ SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
-
OpGen announced completion of study collaboration with Karolinska Institutet on bacterial co-infections in COVID-19 pneumonia patients
On Sept. 28, 2020, OpGen announced the successful completion of the clinical study between its subsidiary, Curetis, and…
-
Tonix Pharma completed the purchase of a facility to house advanced development center for vaccine programs
On Sept. 28, 2020, Tonix Pharmaceuticals announced that it had completed the purchase a 40,000 square foot facility…
-
Immunic announced results from interim safety analysis from ongoing phase 2 CALVID-1 trial of IMU-838 in patients with COVID-19
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
INOVIO reported FDA partial clinical hold for planned phase 2/3 trial of COVID-19 vaccine candidate INO-4800
On Sept. 28, 2020, INOVIO announced the U.S. Food and Drug Administration (FDA) had notified the company that…
-
Evaluation of LamPORE rapid tests for Covid-19 showed high levels of diagnostic sensitivity
On Sept. 25, 2020, scientists from the University of Oxfordﾒs Nuffield Department of Medicine published their evaluation of…
-
CDC’s ACIP recommended routine vaccination with a quadrivalent meningococcal conjugate vaccine for adolescents aged 11 or 12 years, with a booster dose at age 16 years.
On Sept. 25, 2020, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination with a quadrivalent meningococcal…
-
Todos Medical entered Into COVID-19 PCR testing implementation and equipment financing partnership with AID Genomics
On Sept. 25, 2020, Todos Medical announced that it had entered into an implementation and equipment financing partnership…
-
Lumen Bioscience awarded Federal grant to rapidly develop antibody-based Covid-19 therapeutic
On Sept. 24, 2020, Lumen Bioscience and the US Army Medical Research and Development Command, announced an agreement…
-
Y chromosomes of Neandertals and Denisovans was sequenced
On Sept. 24, 2020, an international research team led by the Max Planck Institute for Evolutionary Anthropology in…
-
Scientists discovered genetic and immunologic underpinnings of some cases of severe COVID-19
On Sept. 24, 2020, new findings reported by scientists at the National Institutes of Health and their collaborators…
-
Human heart mapped cell by cell
On Sept. 24, 2020, a team of scientists announced they had created the first atlas of human heart…
-
FDA took actions to help lower US prescription drug prices
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
-
Yale designated labs in three states to provide SalivaDirect COVID-19 test
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
-
Novavax initiated phase 3 efficacy trial of COVID-19 vaccine in the UK
On Sept. 24, 2020, Novavax announced that it had initiated its first Phase 3 study to evaluate the…
